← Home
The Proof · September 7, 2026 · 1h 42m

The Case for Treating Cholesterol Before Plaque Appears | Dr Thomas Dayspring and Dr Dan Soffer

Dr. Dan Soffer, Simon Hill, Dr. Thomas Dayspring
Show Notes

Dr Thomas Dayspring and Dr Dan Soffer, both Masters of the National Lipid Association, join Simon Hill to discuss why nearly all of us have atherosclerosis even when cholesterol is labeled normal. They debate whether ApoB is causal or just necessary, explain the misperception of 'normal' cholesterol, and outline practical tools like LDL-C years and the 2026 dyslipidemia guideline update. The conversation offers an honest look at how experienced clinicians weigh evidence when treating people who feel well.

This summary was generated from show notes and public descriptions, not from a full transcript review. Details may contain inaccuracies.

Highlights

•
ApoB: Cause or Necessary Substrate?
Dayspring argues ApoB is the cause of atherosclerosis; Soffer calls it the necessary substrate.
ClaudeChatGPTGemini
•
'Normal' Cholesterol Is Not Physiological
'Normal' cholesterol is a population average, not a physiological target; the levels we are born with are far lower.
ClaudeChatGPTGemini
•
LDL-C Years: A Quick Cumulative Exposure Metric
LDL-C years is a simple calculation that estimates total lifetime cholesterol burden.
ClaudeChatGPTGemini
•
Statin Muscle Symptoms and the Rechallenge Test
A simple test — likely stopping and rechallenging — can determine whether muscle symptoms are truly statin-related.
ClaudeChatGPTGemini
•
Managing a Healthy 30-Something with Family History and ApoB 100
The clinicians walk through how they would manage a healthy man in his thirties with a strong family history and an ApoB of 100.
ClaudeChatGPTGemini
Was this useful?